Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery

Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Although immunotherapy has shown potential in TNBC patients, clinical studies have only demonstrated a modest response. Therefore, the exploration of immunotherapy in combination with che...

Full description

Bibliographic Details
Main Authors: Olha Kholod, William I. Basket, Jonathan B. Mitchem, Jussuf T. Kaifi, Richard D. Hammer, Christos N. Papageorgiou, Chi-Ren Shyu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
triple-negative breast cancer
exploratory subgroup discovery
chemoimmunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/23/5806

Internet

https://www.mdpi.com/2072-6694/14/23/5806

Similar Items